Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
1cBio CDK7 inhibitor
- Development stage
- Preclinical
- Lead developer
- 1cBio
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
1cBio's CDK7 inhibitor is a small molecule therapeutic currently in preclinical development for the treatment of various solid tumors, with a particular focus on breast cancer and breast cancer with brain metastasis. As an inhibitor of Cyclin-Dependent Kinase 7 (CDK7), the drug targets a key regulator of both the cell cycle and RNA polymerase II-mediated transcription. By blocking CDK7, the molecule disrupts the transcriptional machinery that many cancer cells depend on for survival and proliferation, while also inhibiting cell cycle progression. The program is being developed by 1cBio (also known as Team 1C) to address high unmet needs in metastatic disease, particularly where blood-brain barrier penetration or activity against brain metastases is required.
- Other names
- 1cBio CDK7 inhibitorCDK7 inhibitor (1cBio)
02
Targets
CDK7
Beyond the preview
Go deeper on 1cBio CDK7 inhibitor.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 1cBio CDK7 inhibitor.